Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT06459141

The Effect of Acute Normovolemic Hemodilution in Bone Tumor Surgery

Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2025-03-14

150

Participants Needed

1

Research Sites

99 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The prevention of intraoperative allogenetic blood transfusion has the potential to reduce complications, hospital stays, and long-term prognosis in patients undergoing bone tumor surgery. Data from previous studies suggest that the clinical efficacy of acute normovolemic hemodilution (ANH) has always been controversial, and intraoperative fluid administration strategy is an important confounding factor. The HEAL trial will assess whether ANH will reduce the volume of intraoperative allogeneic red blood cell transfusion when applying goal-directed fluid therapy in patients undergoing bone tumor surgery.

CONDITIONS

Official Title

The Effect of Acute Normovolemic Hemodilution in Bone Tumor Surgery

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 75 years
  • Scheduled for elective bone tumor resection surgery
  • Preoperative hemoglobin level of at least 11 g/dL
Not Eligible

You will not qualify if you...

  • Use of a tourniquet during surgery
  • Undergoing palliative or minimally invasive surgery
  • Body mass index (BMI) less than 18.5 or greater than 30 kg/m2
  • International normalized ratio (INR) greater than 1.5 or platelet count less than 100 x 10^9/L
  • Cardiopulmonary insufficiency
  • Liver or kidney dysfunction
  • Active infection
  • Allergy to succinyl gelatin
  • Pregnancy
  • Declined participation or blood transfusion

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

The Second Affiliated Hospital of Zhejiang University anesthesiology department

Hangzhou, Zhejiang, China, 310000

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

The Effect of Acute Normovolemic Hemodilution in Bone Tumor Surgery | DecenTrialz